Results 11 to 20 of about 5,966 (238)

Identification of gene mutations in six Chinese patients with maple syrup urine disease [PDF]

open access: yesFrontiers in Genetics, 2023
Background: Maple syrup urine disease (MSUD) is a rare autosomal recessive amino acid metabolic disease. This study is to identify the pathogenic genetic factors of six cases of MUSD and evaluates the application value of high-throughput sequencing ...
Lulu Li   +11 more
doaj   +3 more sources

Maple syrup urine disease: mechanisms and management

open access: yesThe Application of Clinical Genetics, 2017
Patrick R Blackburn,1,2,* Jennifer M Gass,1,* Filippo Pinto e Vairo,3,4,* Kristen M Farnham,5 Herjot K Atwal,6 Sarah Macklin,5 Eric W Klee,3,4,7,8 Paldeep S Atwal1,5 1Center for Individualized Medicine, 2Department of Health Sciences Research, Mayo ...
Blackburn PR   +7 more
doaj   +6 more sources

Hyperleucinosis during infections in maple syrup urine disease post liver transplantation

open access: goldMolecular Genetics and Metabolism Reports, 2021
Maple syrup urine disease (MSUD) is due to biallelic variants in one of the three genes: BCKDHA, BCKDHB, and DBT. Branched-chain alpha-ketoacid dehydrogenase complex deficiency and elevated leucine, valine, isoleucine and alloisoleucine in body fluids ...
Laura Guilder   +8 more
doaj   +3 more sources

Metabolic Control and "Ideal" Outcomes in Liver Transplantation for Maple Syrup Urine Disease. [PDF]

open access: greenJ Pediatr, 2021
Ewing CB   +11 more
europepmc   +4 more sources

Two novel mutations in the BCKDHB gene that cause maple syrup urine disease [PDF]

open access: diamondPediatrics and Neonatology, 2018
Background: Maple syrup urine disease (MSUD) is a rare metabolic disorder of autosomal recessive inheritance caused by decreased activity of branched-chain α-ketoacid dehydrogenase complex (BCKD). Mutations in the three genes (BCKDHA, BCKDHB and DBT) are
Bingjuan Han   +4 more
doaj   +2 more sources

Thiamine-responsive maple syrup urine disease missed by newborn screen: A case report [PDF]

open access: yesMolecular Genetics and Metabolism Reports
Maple syrup urine disease (MSUD) is a rare autosomal recessive metabolic disorder caused by a deficiency of the branched-chain α-ketoacid dehydrogenase (BCKAD) complex.
Jariya Upadia   +4 more
doaj   +2 more sources

Acrodermatitis dysmetabolica secondary to isoleucine deficiency in infant with maple syrup urine disease [PDF]

open access: yesDermatology Reports, 2023
Acrodermatitis dysmetabolica (AD) describes eruptions characterized by the clinical triad of acral dermatitis, diarrhea, and alopecia. AD can be caused by various metabolic disorders one of which is maple syrup urine disease (MSUD). We present a 2-month-
Fares A. Alkhayal   +3 more
doaj   +2 more sources

Factors associated with poor outcomes in patients with maple syrup urine disease in a tertiary government hospital: A retrospective cohort study [PDF]

open access: yesJIMD Reports
This study aims to determine the factors associated with mortality and neurodevelopmental morbidity in patients with Maple Syrup Urine Disease (MSUD) seen at a tertiary hospital in the Philippines during a 10‐year period.
Christine Mae S. Avila   +1 more
doaj   +2 more sources

Molecular basis of various forms of maple syrup urine disease in Chilean patients

open access: yesMolecular Genetics & Genomic Medicine, 2021
Background Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disorder caused by the deficient activity of the branched‐chain α‐keto acid dehydrogenase (BCKD) enzymatic complex.
Diana Ruffato Resende Campanholi   +12 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy